Global oncology r&d surges while cancer care disruptions ease, says iqvia institute for human data science

Research triangle park, n.c.--(business wire)--global research and development in oncology continues to surge with historically high levels of trial starts in 2021, up 56% from 2016. also, a record 30 novel active substances launched globally last year, according to a new report from the iqvia institute for human data science on global oncology trends 2022. while disruptions in cancer care are easing, more new patients were presenting to community oncologists with metastatic disease in several
IQV Ratings Summary
IQV Quant Ranking